Diaceutics (LON:DXRX) Insider Nick Roberts Buys 90 Shares

Diaceutics PLC (LON:DXRX) insider Nick Roberts acquired 90 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of GBX 167 per share, for a total transaction of £150.30.

Nick Roberts also recently made the following trade(s):

• On Monday, March 2nd, Nick Roberts acquired 100 shares of Diaceutics stock. The stock was purchased at an average price of GBX 150 per share, for a total transaction of £150.

Diaceutics Trading Up 0.2%

Shares of Diaceutics stock opened at GBX 165.40 on Tuesday. The stock’s 50-day simple moving average is GBX 154.44 and its 200 day simple moving average is GBX 153.63. Diaceutics PLC has a 52-week low of GBX 112.25 and a 52-week high of GBX 177. The stock has a market capitalization of £139.98 million, a P/E ratio of -91.89 and a beta of 0.94. The company has a debt-to-equity ratio of 3.05, a quick ratio of 9.92 and a current ratio of 3.96.

Analyst Ratings Changes

Separately, Shore Capital Group upped their price target on Diaceutics from GBX 180 to GBX 215 and gave the company a “buy” rating in a research report on Thursday, January 15th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of GBX 193.33.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.